239 related articles for article (PubMed ID: 20974624)
1. Multicentric Castleman's disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases.
Sato Y; Kojima M; Takata K; Morito T; Mizobuchi K; Tanaka T; Inoue D; Shiomi H; Iwao H; Yoshino T
J Clin Pathol; 2010 Dec; 63(12):1084-9. PubMed ID: 20974624
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous multicentric Castleman's disease mimicking IgG4-related disease.
Takeuchi M; Sato Y; Takata K; Kobayashi K; Ohno K; Iwaki N; Orita Y; Yoshino T
Pathol Res Pract; 2012 Dec; 208(12):746-9. PubMed ID: 23102767
[TBL] [Abstract][Full Text] [Related]
3. Comparison of plasma cell type of Castleman's disease and IgG4-related sclerosing disease: a histopathological and immunohistochemical study.
Jo JH; Park YS; Jeon YK; Nam SJ; Huh J
Pathobiology; 2011; 78(4):227-32. PubMed ID: 21778790
[TBL] [Abstract][Full Text] [Related]
4. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease.
Sato Y; Kojima M; Takata K; Morito T; Asaoku H; Takeuchi T; Mizobuchi K; Fujihara M; Kuraoka K; Nakai T; Ichimura K; Tanaka T; Tamura M; Nishikawa Y; Yoshino T
Mod Pathol; 2009 Apr; 22(4):589-99. PubMed ID: 19270642
[TBL] [Abstract][Full Text] [Related]
5. A case of IgG4-related disease with features of Mikulicz's disease, and retroperitoneal fibrosis and lymphadenopathy mimicking Castleman's disease.
Takenaka K; Takada K; Kobayashi D; Moriguchi M; Harigai M; Miyasaka N
Mod Rheumatol; 2011 Aug; 21(4):410-4. PubMed ID: 21243399
[TBL] [Abstract][Full Text] [Related]
6. Castleman's disease, intermediate type: a case report.
Raphael V; Lyngdoh RH
Indian J Pathol Microbiol; 2006 Oct; 49(4):603-4. PubMed ID: 17183872
[TBL] [Abstract][Full Text] [Related]
7. Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity.
Cheuk W; Chan JK
Semin Diagn Pathol; 2012 Nov; 29(4):226-34. PubMed ID: 23068302
[TBL] [Abstract][Full Text] [Related]
8. Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients.
Kojima M; Motoori T; Asano S; Nakamura S
Pathol Res Pract; 2007; 203(6):423-31. PubMed ID: 17540509
[TBL] [Abstract][Full Text] [Related]
9. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients.
Oksenhendler E; Duarte M; Soulier J; Cacoub P; Welker Y; Cadranel J; Cazals-Hatem D; Autran B; Clauvel JP; Raphael M
AIDS; 1996 Jan; 10(1):61-7. PubMed ID: 8924253
[TBL] [Abstract][Full Text] [Related]
10. Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide.
Lee FC; Merchant SH
Am J Hematol; 2003 May; 73(1):48-53. PubMed ID: 12701121
[TBL] [Abstract][Full Text] [Related]
11. The analysis of interleukin-6 in patients with systemic IgG4-related plasmacytic syndrome--expansion of SIPS to the territory of Castleman's disease.
Yamamoto M; Takahashi H; Hasebe K; Suzuki C; Naishiro Y; Hayashi T; Yamamoto H; Ishida T; Shinomura Y
Rheumatology (Oxford); 2009 Jul; 48(7):860-2. PubMed ID: 19447768
[No Abstract] [Full Text] [Related]
12. [Castleman's disease in a patient with recurrent reactive lymphadenopathy].
Topal O; Alataş N; Erbek S; Erbek SS; Tosun E
Kulak Burun Bogaz Ihtis Derg; 2008; 18(6):377-80. PubMed ID: 19293629
[TBL] [Abstract][Full Text] [Related]
13. Lymphoplasmacytic infiltrate of regional lymph nodes in Kuttner's tumor (chronic sclerosing sialadenitis): a report of 3 cases.
Kojima M; Miyawaki S; Takada S; Kashiwabara K; Igarashi T; Nakamura S
Int J Surg Pathol; 2008 Jul; 16(3):263-8. PubMed ID: 18573783
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic multicentric Castleman's disease. A clinicopathologic and immunohistochemical study of five cases.
Kojima M; Nakamura S; Nishikawa M; Itoh H; Miyawaki S; Masawa N
Pathol Res Pract; 2005; 201(4):325-32. PubMed ID: 15991840
[TBL] [Abstract][Full Text] [Related]
15. Localization of Epstein-Barr virus in Castleman's disease by in situ hybridization and immunohistochemistry.
Murray PG; Deacon E; Young LS; Barletta JM; Mann RB; Ambinder RF; Rowlands DC; Jones EL; Ramsay AD; Crocker J
Hematol Pathol; 1995; 9(1):17-26. PubMed ID: 7628995
[TBL] [Abstract][Full Text] [Related]
16. A case of multicentric angio-follicular lymph node hyperplasia (Castleman's disease).
Batra Y; Choudhry A; Gupta SD
Trop Gastroenterol; 1999; 20(4):180-1. PubMed ID: 10769608
[No Abstract] [Full Text] [Related]
17. The immunophenotypic patterns of follicle centre and mantle zone in Castleman's disease.
Peh SC; Shaminie J; Poppema S; Kim LH
Singapore Med J; 2003 Apr; 44(4):185-91. PubMed ID: 12952030
[TBL] [Abstract][Full Text] [Related]
18. Increase in soluble CD138 in bronchoalveolar lavage fluid of multicentric Castleman's disease.
Hasegawa M; Betsuyaku T; Yoshida N; Nasuhara Y; Kinoshita I; Ohta S; Itoh T; Park PW; Nishimura M
Respirology; 2007 Jan; 12(1):140-3. PubMed ID: 17207040
[TBL] [Abstract][Full Text] [Related]
19. Post renal transplant Castleman's disease resolved after graft nephrectomy: a case report.
Al Otaibi T; Al Sagheir A; Ludwin D; Meyer R
Transplant Proc; 2007 May; 39(4):1276-7. PubMed ID: 17524952
[TBL] [Abstract][Full Text] [Related]
20. Coexistence of Hodgkin's disease and giant lymph node hyperplasia of the plasma-cell type (Castleman's disease).
Abdel-Reheim FA; Koss W; Rappaport ES; Arber DA
Arch Pathol Lab Med; 1996 Jan; 120(1):91-6. PubMed ID: 8554455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
